Literature DB >> 27181590

Neurodegeneration Alters Metabolic Profile and Sirt 1 Signaling in High-Fat-Induced Obese Mice.

Leandro Ceotto Freitas Lima1,2, Soraya Wilke Saliba2, João Marcus Oliveira Andrade3, Maria Luisa Cunha2, Puebla Cassini-Vieira2, John David Feltenberger4, Lucíola Silva Barcelos2, André Luiz Sena Guimarães3, Alfredo Mauricio Batista de-Paula3, Antônio Carlos Pinheiro de Oliveira2, Sérgio Henrique Sousa Santos5,6.   

Abstract

Different factors may contribute to the development of neurodegenerative diseases. Among them, metabolic syndrome (MS), which has reached epidemic proportions, has emerged as a potential element that may be involved in neurodegeneration. Furthermore, studies have shown the importance of the sirtuin family in neuronal survival and MS, which opens the possibility of new pharmacological targets. This study investigates the influence of sirtuin metabolic pathways by examining the functional capacities of glucose-induced obesity in an excitotoxic state induced by a quinolinic acid (QA) animal model. Mice were divided into two groups that received different diets for 8 weeks: one group received a regular diet, and the other group received a high-fat diet (HF) to induce MS. The animals were submitted to a stereotaxic surgery and subdivided into four groups: Standard (ST), Standard-QA (ST-QA), HF and HF-QA. The QA groups were given a 250 nL quinolinic acid injection in the right striatum and PBS was injected in the other groups. Obese mice presented with a weight gain of 40 % more than the ST group beyond acquiring an insulin resistance. QA induced motor impairment and neurodegeneration in both ST-QA and HF-QA, although no difference was observed between these groups. The HF-QA group showed a reduction in adiposity when compared with the groups that received PBS. Therefore, the HF-QA group demonstrated a commitment-dependent metabolic pathway. The results suggest that an obesogenic diet does not aggravate the neurodegeneration induced by QA. However, the excitotoxicity induced by QA promotes a sirtuin pathway impairment that contributes to metabolic changes.

Entities:  

Keywords:  Huntington’s disease; Metabolic syndrome; Quinolinic acid; Sirtuin

Mesh:

Substances:

Year:  2016        PMID: 27181590     DOI: 10.1007/s12035-016-9927-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  56 in total

1.  Finding a sirtuin truth in Huntington's disease.

Authors:  Albert R La Spada
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

Review 2.  Dietary (sensory) variety and energy balance.

Authors:  Megan A McCrory; Aoife Burke; Susan B Roberts
Journal:  Physiol Behav       Date:  2012-06-21

3.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Authors:  Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

Review 4.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

5.  Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease.

Authors:  Jitendriya Mishra; Anil Kumar
Journal:  Neurotox Res       Date:  2014-04-22       Impact factor: 3.911

6.  Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

Authors:  Patrick Weydt; Victor V Pineda; Anne E Torrence; Randell T Libby; Terrence F Satterfield; Eduardo R Lazarowski; Merle L Gilbert; Gregory J Morton; Theodor K Bammler; Andrew D Strand; Libin Cui; Richard P Beyer; Courtney N Easley; Annette C Smith; Dimitri Krainc; Serge Luquet; Ian R Sweet; Michael W Schwartz; Albert R La Spada
Journal:  Cell Metab       Date:  2006-10-19       Impact factor: 27.287

7.  Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Authors:  Bronwen Martin; Wayne Chadwick; Wei-na Cong; Nick Pantaleo; Caitlin M Daimon; Erin J Golden; Kevin G Becker; William H Wood; Olga D Carlson; Josephine M Egan; Stuart Maudsley
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

8.  Huntington's disease does not appear to increase the risk of diabetes mellitus.

Authors:  T W Boesgaard; T T Nielsen; K Josefsen; T Hansen; T Jørgensen; O Pedersen; A Nørremølle; J E Nielsen; L Hasholt
Journal:  J Neuroendocrinol       Date:  2009-07-07       Impact factor: 3.627

Review 9.  Brain activation of SIRT1: role in neuropathology.

Authors:  Alanna Fernandes Paraíso; Keila Lopes Mendes; Sergio Henrique Sousa Santos
Journal:  Mol Neurobiol       Date:  2013-04-25       Impact factor: 5.590

10.  Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice.

Authors:  João Marcus Oliveira Andrade; Alanna Fernandes Paraíso; Zélia Menezes Garcia; Adaliene Versiani Matos Ferreira; Ruben D M Sinisterra; Frederico B Sousa; André Luiz Sena Guimarães; Alfredo Maurício Batista de Paula; Maria José Campagnole-Santos; Robson Augusto dos Santos; Sérgio Henrique Sousa Santos
Journal:  Peptides       Date:  2014-03-15       Impact factor: 3.750

View more
  5 in total

1.  SIRT1 Overexpression in Mouse Hippocampus Induces Cognitive Enhancement Through Proteostatic and Neurotrophic Mechanisms.

Authors:  Rubén Corpas; Susana Revilla; Suzanna Ursulet; Marco Castro-Freire; Perla Kaliman; Valérie Petegnief; Lydia Giménez-Llort; Chamsy Sarkis; Mercè Pallàs; Coral Sanfeliu
Journal:  Mol Neurobiol       Date:  2016-09-10       Impact factor: 5.590

Review 2.  Physical exercise, obesity, inflammation and neutrophil extracellular traps (NETs): a review with bioinformatics analysis.

Authors:  Berenilde Valeria Oliveira de Sousa; Daniela Fernanda de Freitas; Renato Sobral Monteiro-Junior; Iara Heloisa Ramos Mendes; Jaciara Neves Sousa; Victor Hugo Dantas Guimarães; Sérgio Henrique Sousa Santos
Journal:  Mol Biol Rep       Date:  2021-05-20       Impact factor: 2.316

3.  TLR4 mutation protects neurovascular function and cognitive decline in high-fat diet-fed mice.

Authors:  Nathalie Obadia; Giulia Andrade; Marina Leardini-Tristão; Letícia Albuquerque; Celina Garcia; Flavia Lima; Júlio Daleprane; Hugo C Castro-Faria-Neto; Eduardo Tibiriçá; Vanessa Estato
Journal:  J Neuroinflammation       Date:  2022-04-29       Impact factor: 9.587

4.  Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder.

Authors:  Bidisha Rajkhowa; Sidharth Mehan; Pranshul Sethi; Aradhana Prajapati; Manisha Suri; Sumit Kumar; Sonalika Bhalla; Acharan S Narula; Abdulrahman Alshammari; Metab Alharbi; Nora Alkahtani; Saeed Alghamdi; Reni Kalfin
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-02

5.  Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.

Authors:  Jing Zou; Zhaoyu Chen; Xiaobo Wei; Zhigang Chen; Yongmei Fu; Xiaoyan Yang; Dan Chen; Rui Wang; Peter Jenner; Jia-Hong Lu; Min Li; Zhuohua Zhang; Beisha Tang; Kunlin Jin; Qing Wang
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.